Masco Corporation (MAS) Q4 2024 Earnings Call Transcript — Neutral
MAS Seeking Alpha — February 11, 2025Masco Corporation (NYSE:MAS ) Q4 2024 Results Conference Call February 11, 2025 8:00 AM ET Company Participants Robin Zondervan - Vice President, Investor Relations, FP&A of Masco Corp Rick Westenberg - Vice President, Chief Financial Officer Keith Allman - President, Chief Executive Officer Conference Call Participants Stephen Kim - Evercore ISI John Lovallo - UBS Anthony Pettinari - Citi Sam Reid - Wells Fargo Matthew Bouley - Barclays Trevor Allinson - Wolfe Research Susan Maklari - Goldman Sachs Adam Baumgarten - Zelman & Associates Operator Good morning, ladies and gentlemen. Welcome to the Masco Corporation 2024 Fourth Quarter and Full …

Is Costco Stock a Buy, Hold or Sell After January Sales Results? — Positive
COST Zacks Investment Research — February 11, 2025Can Costco's strong sales and global expansion sustain growth, making its premium valuation worth it? Its solid fundamentals may be too strong to ignore.

Decent Global Bond Issuance Volume to Support Moody's Q4 Earnings — Positive
MCO Zacks Investment Research — February 11, 2025MCO's quarterly results are expected to benefit from decent global bond issuance and robust analytics demand. Yet, high costs are likely to have hurt.

What's in Store for Federal Realty in Q4 Earnings Season? — Positive
FRT Zacks Investment Research — February 11, 2025FRT's fourth-quarter results are likely to benefit from the healthy demand for its retail assets, though higher interest expenses may dampen the results.

Carrier Global Corporation (CARR) Q4 2024 Earnings Call Transcript — Neutral
CARR Seeking Alpha — February 11, 2025Carrier Global Corporation (NYSE:CARR ) Q4 2024 Earnings Conference Call February 11, 2025 7:30 AM ET Company Participants Michael Rednor - VP, IR David Gitlin - Chairman & CEO Patrick Goris - SVP & CFO Conference Call Participants Jeffrey Sprague - Vertical Research Partners Andrew Kaplowitz - Citigroup Julian Mitchell - Barclays Stephen Tusa - JPMorgan Joe Ritchie - Goldman Sachs Nigel Coe - Wolfe Research Deane Dray - RBC Capital Markets Joseph O'Dea - Wells Fargo Andrew Obin - Bank of America Chris Snyder - Morgan Stanley Tommy Moll - Stephens Noah Kaye - Oppenheimer Operator Good morning, and …

Defense IT specialist Leidos Holdings (LDOS -5.41%) beat quarterly expectations, but investors apparently were hoping for more. Leidos shares fell 7% at market open Tuesday and were down 5% as of 11 a.m.

Class Action Filed Against Crocs, Inc. (CROX) Seeking Recovery for Investors - Contact Levi & Korsinsky — Neutral
CROX Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=128801&wire=1 or contact Joseph E. Levi, Esq.

ENPH DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Important February 11 Deadline in Securities Class Action - ENPH — Neutral
ENPH Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Enphase Energy, Inc. (NASDAQ:ENPH) between April 25, 2023 and October 22, 2024, both dates inclusive (the "Class Period"), of the important February 11, 2025 lead plaintiff deadline. SO WHAT: If you purchased Enphase common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Class Action Filed Against Novo Nordisk A/S (NVO) Seeking Recovery for Investors - Contact Levi & Korsinsky — Neutral
NVO Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=128798&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT — Neutral
APLT Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128800&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of FTAI Aviation Ltd. (FTAI) Shareholders — Neutral
FTAI Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=128799&wire=1 or contact Joseph E.

UPDATE - Tidal Trust II Announces Name Change of STKD Bitcoin & Gold ETF — Neutral
AA GlobeNewsWire — February 11, 2025CHICAGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tidal Trust II today announced that the STKD Bitcoin & Gold ETF (BTGD) will undergo a name change to STKd 100% Bitcoin & 100% Gold ETF, effective February 18, 2025. The fund will continue to be listed on The Nasdaq Stock Market, LLC under its current ticker symbol, BTGD.

APLT DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT — Neutral
APLT GlobeNewsWire — February 11, 2025NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.

Bulls Chasing Morgan Stanley, Whose Dividend Growth Case Remains Strong — Positive
MS Seeking Alpha — February 11, 2025Morgan Stanley gets upgraded to a buy from my prior hold rating, as several upside factors outweigh the high share price and overvaluation. The dividend yield of 2.6% is beating key peers, while the firm has a proven 5 year dividend CAGR. Q4 results not only saw YoY earnings growth, but pointed to growth in AUM and client inflows, which could drive future fees.

Ford Motor has been named as a Top 10 dividend stock, according the most recent Dividend Channel ''DividendRank'' report. The report noted that among the coverage universe, F shares displayed both attractive valuation metrics and strong profitability metrics.

Grab These 3 Stocks With Upside as Semiconductor Sales Skyrocket — Positive
NVDA RFIL TSM Zacks Investment Research — February 11, 2025Stocks like NVDA, TSM and RFIL are poised to gain from the jump in semiconductor sales.

BAC Mulls Over Buying $9B Residential Mortgage Loans From TD — Positive
BAC Zacks Investment Research — February 11, 2025Bank of America intends to acquire residential mortgage loans from TD to expand mortgage lending and strengthen its loan portfolio.

KSPI DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Joint Stock Company Kaspi.kz Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action First Filed by the Firm – KSPI — Neutral
KSPI GlobeNewsWire — February 11, 2025NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) between January 19, 2024 and September 19, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.

Shares of Axsome Therapeutics (AXSM 4.36%) are up on Tuesday. The company's stock gained 4.1% as of 10:20 a.m.

Gold hits all-time highs in all major currencies, Germany and China could be the next drivers of the rally - WGC — Positive
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — February 11, 2025Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
